Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
12.28
+0.27 (2.25%)
May 8, 2025, 4:00 PM - Market closed
Elanco Animal Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 4,427 | 4,439 | 4,417 | 4,411 | 4,764 | 3,271 | Upgrade
|
| Revenue Growth (YoY) | 1.42% | 0.50% | 0.14% | -7.41% | 45.64% | 6.51% | Upgrade
|
| Cost of Revenue | 1,997 | 2,003 | 1,931 | 1,913 | 2,068 | 1,577 | Upgrade
|
| Gross Profit | 2,430 | 2,436 | 2,486 | 2,498 | 2,696 | 1,694 | Upgrade
|
| Selling, General & Admin | 1,312 | 1,308 | 1,280 | 1,259 | 1,395 | 988 | Upgrade
|
| Research & Development | 351 | 344 | 327 | 321 | 369 | 329 | Upgrade
|
| Operating Expenses | 2,185 | 2,179 | 2,155 | 2,108 | 2,320 | 1,677 | Upgrade
|
| Operating Income | 245 | 257 | 331 | 390 | 376 | 17 | Upgrade
|
| Interest Expense | -209 | -235 | -277 | -241 | -236 | -150 | Upgrade
|
| Currency Exchange Gain (Loss) | 12 | -12 | -40 | -28 | -35 | -4 | Upgrade
|
| Other Non Operating Income (Expenses) | -39 | -12 | -12.5 | -10 | 22 | -60 | Upgrade
|
| EBT Excluding Unusual Items | 9 | -2 | 1.5 | 111 | 127 | -197 | Upgrade
|
| Merger & Restructuring Charges | -24 | -62 | -93 | -98 | -336 | -702 | Upgrade
|
| Impairment of Goodwill | - | - | -1,042 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 11 | Upgrade
|
| Gain (Loss) on Sale of Assets | 647 | 640 | - | - | - | 211 | Upgrade
|
| Asset Writedown | -81 | -81 | -32 | -81 | - | - | Upgrade
|
| Legal Settlements | - | - | -27.5 | - | -10 | - | Upgrade
|
| Other Unusual Items | -15 | -7 | -2 | -4 | -352 | - | Upgrade
|
| Pretax Income | 536 | 488 | -1,195 | -72 | -571 | -677 | Upgrade
|
| Income Tax Expense | 163 | 150 | 36 | 6 | -88 | -103 | Upgrade
|
| Net Income | 373 | 338 | -1,231 | -78 | -483 | -574 | Upgrade
|
| Net Income to Common | 373 | 338 | -1,231 | -78 | -483 | -574 | Upgrade
|
| Shares Outstanding (Basic) | 494 | 494 | 492 | 488 | 487 | 441 | Upgrade
|
| Shares Outstanding (Diluted) | 498 | 497 | 492 | 488 | 487 | 441 | Upgrade
|
| Shares Change (YoY) | 1.06% | 1.02% | 0.82% | 0.23% | 10.38% | 19.20% | Upgrade
|
| EPS (Basic) | 0.75 | 0.68 | -2.50 | -0.16 | -0.99 | -1.30 | Upgrade
|
| EPS (Diluted) | 0.75 | 0.68 | -2.50 | -0.16 | -0.99 | -1.30 | Upgrade
|
| Free Cash Flow | 347 | 394 | 131 | 281 | 324 | -176 | Upgrade
|
| Free Cash Flow Per Share | 0.70 | 0.79 | 0.27 | 0.57 | 0.67 | -0.40 | Upgrade
|
| Gross Margin | 54.89% | 54.88% | 56.28% | 56.63% | 56.59% | 51.79% | Upgrade
|
| Operating Margin | 5.53% | 5.79% | 7.49% | 8.84% | 7.89% | 0.52% | Upgrade
|
| Profit Margin | 8.43% | 7.61% | -27.87% | -1.77% | -10.14% | -17.55% | Upgrade
|
| Free Cash Flow Margin | 7.84% | 8.88% | 2.97% | 6.37% | 6.80% | -5.38% | Upgrade
|
| EBITDA | 862 | 879 | 971 | 1,007 | 1,040 | 499 | Upgrade
|
| EBITDA Margin | 19.47% | 19.80% | 21.98% | 22.83% | 21.83% | 15.25% | Upgrade
|
| D&A For EBITDA | 617 | 622 | 640 | 617 | 664 | 482 | Upgrade
|
| EBIT | 245 | 257 | 331 | 390 | 376 | 17 | Upgrade
|
| EBIT Margin | 5.53% | 5.79% | 7.49% | 8.84% | 7.89% | 0.52% | Upgrade
|
| Effective Tax Rate | 30.41% | 30.74% | - | - | - | - | Upgrade
|
| Advertising Expenses | - | 236 | 207 | 201 | 248 | - | Upgrade
|
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.